BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33307936)

  • 1. Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study.
    Divino V; Ramasamy A; Anupindi VR; Eriksen KT; Olsen AH; DeKoven M; Meincke HH
    J Manag Care Spec Pharm; 2021 Feb; 27(2):210-222. PubMed ID: 33307936
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States.
    Li Q; Blume SW; Huang JC; Hammer M; Ganz ML
    J Med Econ; 2015; 18(12):1020-8. PubMed ID: 26134917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic value of nonsurgical weight loss in adults with obesity.
    Ding Y; Fan X; Blanchette CM; Smolarz BG; Weng W; Ramasamy A
    J Manag Care Spec Pharm; 2021 Jan; 27(1):37-50. PubMed ID: 33164723
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Weight Change on Economic Outcomes Among Persons with Type 2 Diabetes Mellitus in the United States: Beyond Glycemic Control.
    Karkare S; Fridman M; Dang-Tan T; Lu J; Smolarz BG; DeKoven M; Iyer NN
    J Manag Care Spec Pharm; 2019 Jun; 25(6):658-668. PubMed ID: 30730232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals.
    Pearson-Stuttard J; Banerji T; Capucci S; de Laguiche E; Faurby MD; Haase CL; Sommer Matthiessen K; Near AM; Tse J; Zhao X; Evans M
    Int J Obes (Lond); 2023 Dec; 47(12):1239-1246. PubMed ID: 37723273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease.
    Hong YD; Onukwugha E; Slejko JF
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1353-1362. PubMed ID: 32996389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight-year trends in obesity-related complications and health care cost progression in a US population with obesity: A retrospective cohort study.
    Evans M; Anupindi VR; DeKoven M; de Laguiche E; Divino V; Faurby MD; Haase CL; Sommer Matthiessen K; Pearson-Stuttard J
    Diabetes Obes Metab; 2023 Feb; 25(2):536-544. PubMed ID: 36263756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
    Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.
    Haase CL; Varbo A; Laursen PN; Schnecke V; Balen AH
    Hum Reprod; 2023 Mar; 38(3):471-481. PubMed ID: 36637246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of body mass index on surgical outcomes, narcotics consumption, and hospital costs following anterior cervical discectomy and fusion.
    Narain AS; Hijji FY; Haws BE; Kudaravalli KT; Yom KH; Markowitz J; Singh K
    J Neurosurg Spine; 2018 Feb; 28(2):160-166. PubMed ID: 29192877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic impact of obesity in Kuwait: a micro-costing study evaluating the burden of obesity-related comorbidities.
    Al-Sabah S; ElShamy A; Jois S; Low K; Gras A; Gulnar EP
    J Med Econ; 2023; 26(1):1368-1376. PubMed ID: 37853705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct medical costs of obesity in the United States and the most populous states.
    Cawley J; Biener A; Meyerhoefer C; Ding Y; Zvenyach T; Smolarz BG; Ramasamy A
    J Manag Care Spec Pharm; 2021 Mar; 27(3):354-366. PubMed ID: 33470881
    [No Abstract]   [Full Text] [Related]  

  • 13. Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs.
    Ford JH; Schroeder K; Nyhuis AW; Foster SA; Aurora SK
    J Manag Care Spec Pharm; 2019 Jan; 25(1):46-59. PubMed ID: 30044691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
    Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
    J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pain Severity and Opioid Use on Health Care Resource Utilization and Costs Among Patients with Knee and Hip Osteoarthritis.
    Wei W; Gandhi K; Blauer-Peterson C; Johnson J
    J Manag Care Spec Pharm; 2019 Sep; 25(9):957-965. PubMed ID: 31456495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.
    Campbell A; Cong Z; Agodoa I; Song X; Martinez DJ; Black D; Lew CR; Varker H; Chan C; Lanzkron S
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1121-1129. PubMed ID: 32597290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database.
    MedSci KKF; Schnecke V; Haase CL; Harder-Lauridsen NM; Rathor N; Sommer K; Morgen CS
    Diabetes Obes Metab; 2023 Sep; 25(9):2669-2679. PubMed ID: 37283064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
    Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL
    J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States.
    Bell CF; Blauer-Peterson C; Mao J
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1249-1259. PubMed ID: 34165321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.